American Society of Clinical Oncology

SHERPA: White

People

  1. Hudis
    Hudis
  2. Robson
    Robson
  3. Norton
    Norton
  4. Offit
    Offit
  5. Seidman
    Seidman
  6. Traina
    Traina
  7. Dang
    Dang
  8. Modi
    Modi
  9. Solit
    Solit
  10. Stadler
    Stadler

Groups

  1. Breast Medicine Service (785)
  2. Department of Medicine (785)
  3. Solid Tumor Oncology Division (785)
  4. Survivorship Research (556)
  5. Population Sciences Research Program (328)
  6. GSK Faculty (211)
  7. Epidemiology and Biostatistics (207)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (198)
  9. Biostatistics Service (158)
  10. Surgery (119)
Search Within
  1. "Breast Medicine Service"
Formats
  1. Meeting Abstract (509)
  2. Journal Article (258)
  3. Guidelines (9)
  4. Editorial (4)
  5. Review (3)
  6. Correspondence (2)
Groups
  1. Breast Medicine Service (785)
  2. Department of Medicine (785)
  3. Solid Tumor Oncology Division (785)
  4. Survivorship Research (556)
  5. Population Sciences Research Program (328)
  6. GSK Faculty (211)

More Groups

People
  1. Clifford Hudis (248)
  2. Mark Robson (172)
  3. Larry Norton (152)
  4. Kenneth Offit (85)
  5. Andrew Seidman (84)
  6. Sujata Patil (79)

More People

Years
  1. 2024 (1)
  2. 2023 (39)
  3. 2022 (48)
  4. 2021 (36)
  5. 2020 (49)
  6. 2019 (47)

More Years

Publications
  1. Journal of Clinical Oncology (748)
  2. JCO Precision Oncology (21)
  3. American Society of Clinical Oncology Educational Book (7)
  4. Journal of Oncology Practice (6)
  5. ASCO Connection (1)
  6. JCO Clinical Cancer Informatics (1)

More Publications

Results (785)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Germline testing in patients with breast cancer: ASCO-Society of Surgical Oncology guideline
    Journal Article

    Bedrosian, I.; Somerfield, M. R.; Achatz, M. I.; Boughey, J. C.; Curigliano, G.; Friedman, S.; Kohlmann, W. K.; Kurian, A. W.; Laronga, C.; Lynce, F.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Financial toxicity monitoring in a randomized controlled trial of patient-reported outcomes during cancer treatment (Alliance AFT-39)
    Journal Article

    Blinder, V. S.; Deal, A. M.; Ginos, B.; Jansen, J.; Dueck, A. C.; Mazza, G. L.; Henson, S.; Carr, P.; Rogak, L. J.; Weiss, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A randomized phase III clinical trial of acupuncture for chemotherapy-induced peripheral neuropathy in survivors of cancer
    Meeting Abstract

    Lopez-Nieves, I.; Chiang, C.; Han, K.; Piulson, L.; Seluzicki, C.; Weitzman, M.; Zhang, Y. L.; Zhi, I.; Bao, T.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A randomized phase III clinical trial of yoga for chemotherapy-induced peripheral neuropathy treatment
    Meeting Abstract

    Saint, K.; Han, K.; Piulson, L.; Seluzicki, C.; Zhi, I.; Bao, T.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Harnessing olaparib, palbociclib, and endocrine therapy: A phase I/II trial of olaparib, palbociclib and fulvestrant in patients with BRCA mutation-associated, hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (HOPE)
    Meeting Abstract

    Torres, A.; Aaron, M.; White, L.; D'Andrea, K.; Narayan, V.; Knollman, H. M.; Bradbury, A. R.; Tung, N. M.; Robson, M. E.; Nathanson, K.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • evERA Breast Cancer (BC): Phase III study of giredestrant + everolimus vs exemestane + everolimus in patients (pts) with estrogen receptor-positive, HER2-negative locally advanced or metastatic BC (ER+, HER2– LA/mBC)
    Meeting Abstract

    Mayer, E. L.; Tolaney, S. M.; Brufsky, A.; Gradishar, W. J.; Jhaveri, K. L.; Martin, M.; Moscetti, L.; Schneeweiss, A.; Vidal, G. A.; Cortazar, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The ARETHA study: A phase 2 randomized control trial of eribulin with evexomostat (SDX-7320) or placebo for patients with metastatic triple-negative breast cancer (TNBC) and metabolic dysfunction
    Meeting Abstract

    Shen, S.; Solomon, V.; Williams, D.; Robson, M. E.; Norton, L.; Traina, T. A.; Iyengar, N. M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A single-arm phase 2 study of peri-operative immune checkpoint inhibition and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer
    Meeting Abstract

    McArthur, H. L.; Comen, E. A.; Bryce, Y.; Solomon, S. B.; Leal, J. H. S.; Abaya, C. D.; Martinez, C.; Basho, R. K.; McAndrew, P.; Larkin, B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Early integration of exercise into breast cancer care: The MSK healthy living program
    Meeting Abstract

    Rowed, K.; Shen, S.; Smith, A.; Kelly, B.; Magnoli, R.; Corcoran, S.; Emerzian, M.; Ackerman, K.; Cruz, C.; Salehi, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Real-world clinical outcomes in patients (pts) with HR+/HER2- metastatic breast cancer (mBC) treated with chemotherapy (CT) in the United States (US)
    Meeting Abstract

    Tolaney, S. M.; Punie, K.; Kurian, A. W.; Ntalla, I.; Verret, W.; Sadetsky, N.; Sjekloca, N.; Stokes, M.; Jhaveri, K. L.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save